Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis

Published:2010-05-05 Issue:6 Volume:87 Page:679-685
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Rice C M,Mallam E A,Whone A L,Walsh P,Brooks D J,Kane N,Butler S R,Marks D I,Scolding N J

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference50 articles.

1. Cortical demyelination and diffuse white matter injury in multiple sclerosis

2. Transplantation Options for Therapeutic Central Nervous System Remyelination

3. High-Dose Immunosuppression and Autologous Hematopoietic Stem Cell Rescue for Severe Multiple Sclerosis

4. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism

5. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study;Multiple Sclerosis and Related Disorders;2023-10

2. The influence of yttrium and manganese additions on the degradation and biocompatibility of magnesium-zinc-based alloys: In vitro and in vivo studies;Journal of Magnesium and Alloys;2022-07

3. Opportunities and challenges: mesenchymal stem cells in the treatment of multiple sclerosis;International Journal of Neuroscience;2022-05-17

4. Repeat infusion of autologous bone marrow cells in progressive multiple sclerosis – A phase I extension study (SIAMMS II);Multiple Sclerosis and Related Disorders;2022-05

5. Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis;Biomolecules;2022-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3